Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Xilio Therapeutics, Inc. | 33,250 | reported | 01 Jan 2026 | tx 20+1,767,178−258,460 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 Jan 2026 | EXERCISE | Xilio Therapeutics, Inc. | 16,625 | — | |
| 31 Dec 2025 | GRANT_AWARD | Xilio Therapeutics, Inc. | 451,885 | 0.00 USD | deriv |
| 01 Jan 2026 | EXERCISE | Xilio Therapeutics, Inc. | 16,625 | 0.00 USD | deriv |
| 21 Nov 2025 | GRANT_AWARD | Xilio Therapeutics, Inc. | 106,000 | — | deriv |
| 21 Nov 2025 | GRANT_AWARD | Xilio Therapeutics, Inc. | 44,210 | — | deriv |
| 21 Nov 2025 | OTHER | Xilio Therapeutics, Inc. | 44,210 | — | deriv |
| 21 Nov 2025 | GRANT_AWARD | Xilio Therapeutics, Inc. | 625,000 | 0.00 USD | deriv |
| 21 Nov 2025 | OTHER | Xilio Therapeutics, Inc. | 106,000 | — | deriv |
| 21 Nov 2025 | OTHER | Xilio Therapeutics, Inc. | 15,000 | — | deriv |
| 21 Nov 2025 | OTHER | Xilio Therapeutics, Inc. | 25,000 | — | deriv |
| 21 Nov 2025 | GRANT_AWARD | Xilio Therapeutics, Inc. | 35,000 | — | deriv |
| 21 Nov 2025 | OTHER | Xilio Therapeutics, Inc. | 35,000 | — | deriv |
| 21 Nov 2025 | GRANT_AWARD | Xilio Therapeutics, Inc. | 15,000 | — | deriv |
| 21 Nov 2025 | GRANT_AWARD | Xilio Therapeutics, Inc. | 25,000 | — | deriv |
| 01 Jan 2025 | EXERCISE | Xilio Therapeutics, Inc. | 16,625 | — | |
| 01 Jan 2025 | EXERCISE | Xilio Therapeutics, Inc. | 16,625 | 0.00 USD | deriv |
| 01 Jan 2025 | GRANT_AWARD | Xilio Therapeutics, Inc. | 200,000 | 0.00 USD | deriv |
| 01 May 2024 | GRANT_AWARD | Xilio Therapeutics, Inc. | 59,333 | 0.00 USD | deriv |
| 01 Jan 2024 | GRANT_AWARD | Xilio Therapeutics, Inc. | 66,500 | 0.00 USD | deriv |
| 05 Sept 2023 | GRANT_AWARD | Xilio Therapeutics, Inc. | 106,000 | 0.00 USD | deriv |